"Microsoft (NASDAQ: MSFT) is a well-run company with a fortress-like balance sheet," says growth stock expert Brandon Clay.

In his Invest with an Edge he suggests, "Maicrosoft's war chest of cash and their ability to sparkle with products like Bing makes the company an attractive long-term bet." Here's the advisor's review.

"Microsoft was once the kind of stock investors dreamed of owning. Rising thousands of percent from its IPO in the mid-1980s to the late 1990s, Microsoft was at one point the largest U.S. company by market cap.

"As technology evolved and Microsoft matured, Wall Street turned its focus to 'sexier' areas of technology like Internet stocks. Operating system software wasn't the in-thing anymore. Microsoft became a value stock rather than a growth play.

Continue reading Microsoft (MSFT) 'Fortress-like' balance sheet

Microsoft (MSFT) 'Fortress-like' balance sheet originally appeared on BloggingStocks on Wed, 12 Aug 2009 11:00:00 EST. Please see our terms for use of feeds.

"Health care reform could mean opportunities for astute investors," says Brandon Clay in his Invest With an Edge.

Here, eyes two biotech ETFs that "should be on everyone's watch list." The advisor notes, "With health care on the front burner in Washington, these biotechnology ETFs may finally be ready to pop."

"Investors in health care should think outside the realm of traditional pharmaceutical companies and health insurers. Those sectors are each facing headwinds that make stock picking difficult.

"In addition, several big pharma companiesare desperate to reload their empty pipelines in the face of increased competition from generic drug makers.

Continue reading Biotech ETFs: Best bets on health care reform

Biotech ETFs: Best bets on health care reform originally appeared on BloggingStocks on Fri, 10 Jul 2009 11:40:00 EST. Please see our terms for use of feeds.

"Who will gain from the ongoing troubles at the Big-3 automakers in the US?" asks growth stock specialist Brandon Clay.

In his Invest with an Edge, the growth stock advisors takes a look at Tata Motors Ltd. (NYSE: TTM) which is expected to launch the world's cheapest car. Here's the advisor's review.

"Tata Motors is part of one of the largest manufacturing entities on the planet, will soon release the world's cheapest automobile in the United States.

"Debuting at $2000, the Tata Nano is set for a July 2009 delivery. Tata already has 1 million reservations for their mini-car. If they could deliver, it would easily become the best-selling car this year.

Continue reading Tata Motors (TTM): Mini-car opportunity

Tata Motors (TTM): Mini-car opportunity originally appeared on BloggingStocks on Thu, 14 May 2009 10:30:00 EST. Please see our terms for use of feeds.

"Now could be your chance to pick up Coinstar (NASDAQ: CSTR) at a bargain," Brandon Clay pointing to the firm whose macbhines turn coins into cash. In his Invest with an Edge he states, "We recommend the stock as a recession-resistant, consumer play in a shaky market."

"There are three reasons why we like Constar. First, it's a consumer-savvy play. The company is built on perennial consumer-driven services.

"Their flagship Coinstar machine turns idle change into cash. For every dollar consumers drop into the grate, Coinstar makes $0.089. It may not seem like much, but this simple idea grew CSTR from an idea in 1992, to a $912 million company last year.

Continue reading Coinstar (CSTR): Coins to cash ... plus video rentals

Coinstar (CSTR): Coins to cash ... plus video rentals originally appeared on BloggingStocks on Thu, 16 Apr 2009 14:45:00 EST. Please see our terms for use of feeds.

Two leading growth stock expert, Brandon Clay, editor of Invest with an Edge, and Alexander Green, editor of The Oxford Club, turn to automated blood testing equipment maker Immucor (NASDAQ: BLUD) as a recession-resistant buy.

Clay suggest, "A good bet is to go with the strongest stock in that particular sector at the time of your pickThat way, the company you select at least has the momentum of the sector backing it. Typically the medical industry performs better than the overall market in a downturn. This recession has been no different.

"As we dug deeper into health care, one company surfaced that was worth our attention. Immucor is a blood testing equipment manufacturer specializing in pre-transfusion diagnostics.

"Established in 1982, they brought their first patent to market four years later. Since then they've become a leader in blood diagnostics and blood bank technology.

Continue reading Immucor (BLUD): Two experts bank on blood bank buy

Immucor (BLUD): Two experts bank on blood bank buy originally appeared on BloggingStocks on Mon, 23 Feb 2009 14:00:00 EST. Please see our terms for use of feeds.

"If you're going to stay invested, you should look to defensive sectors," explain Ron Rowland and Brandon Clay, who point to consumer staples as a top pick for the current market environment.

In their Invest with an Edge, the advisors explain, "Perhaps the best way to stay defensive is with the Consumer Staples Select Sector SPDR (NYSE: XLP), an exchange traded fund.

"In a bear market, opportunities are usually limited to certain sectors. Surveying the investment horizon, we think the consumer staples sector has the best opportunity for growth in this economy.

"Regardless how the economy acts, people still eat. Consumers may not shop at Whole Foods, but they'll still buy groceries. Companies like Wal-Mart (NYSE: WMT) and Safeway (NYSE: SWY) will continue to rake in revenues from hungry customers.

"In addition, these companies should continue to receive additional revenue from consumers who normally shop at specialty stores, but can no longer afford to.

"Consumers may not be shopping at Sharper Image any more, but there are other creature comforts that will be difficult for Americans to abandon.

"Coca-Cola (NYSE: KO) and PepsiCo (NYSE: PEP) will still sell products during a prolonged downturn. In addition, companies providing toiletries and convenience like Procter and Gamble and CVS Pharmacy stand to do well during a shifty economy.

Continue reading Stay defensive: Invest in consumer staples

Stay defensive: Invest in consumer staples originally appeared on BloggingStocks on Wed, 26 Nov 2008 13:05:00 EST. Please see our terms for use of feeds.

"Although equities tend to have attractive multi-year growth rates, there is always risk," caution Ron Rowland and Brandon Clay.

In their Invest with an Edge, they explain, "That's why investors have been taking a second look at bonds, specifically municipal bonds." Here's an ETF offering exposure to the muni bond sector.

"Affectionately called 'munis', municipal bonds have enjoyed a resurgence among retail investors, who are buying munis for three reasons:

1) Munis Have High Yield & No Taxes in Difficult Markets

"Municipal bonds are unique investment vehicles. They offer yields, but the interest is not taxed by the IRS. That way, the 'effective' yield for the muni is often higher than on taxable bonds. Moreover, as prices for munis have been falling, yields have been rising.

2) Munis Are Relatively Safe Investments

"When you're buying a muni bond, you're actually loaning to a state/local government or their agencies. Although cities can go bankrupt - thus preventing you from receiving back your initial investment - at least we can vote on governors and mayors.

"As a result, munis are a safer investment than many corporate bonds. Munis are one way for investors to find safety in this market.

Continue reading For stable income consider muni bond ETF

For stable income consider muni bond ETF originally appeared on BloggingStocks on Thu, 13 Nov 2008 17:40:00 EST. Please see our terms for use of feeds.

In the latest annual survey in Barron's of professional investors Johnson and Johnson (NYSE: JNJ) was rated the world's most respected company," reports Ron Rowland and Brandon Clay.

In Invest With an Edge, the advisors look at the 123-company, which he selects as " a solid healthcare pick in a strong long-term uptrend."

"This New Jersey-based company has come a long way since corner drugstores sold their baby powder. Beginning as a pioneer in sterile medical supplies, they expanded into pharmaceuticals and related consumer products.

"Over the years, they've released ubiquitous brands such as Band-Aid, Rogaine, Listerine, Tylenol, even Splenda. Johnson and Johnson has become a household name.

"However, Johnson & Johnson is a healthcare company with deeper product lines; it is ivided into three segments: Consumer, Pharmaceutical and Medical Devices & Diagnostics.

Continue reading Johnson & Johnson (JNJ): The most 'respected' company

Johnson & Johnson (JNJ): The most 'respected' company originally appeared on BloggingStocks on Wed, 24 Sep 2008 12:15:00 EST. Please see our terms for use of feeds.

"For the next two-and-a-half weeks, almost all you'll hear in the news will be related to the 29th Olympiad in Beijing," points out Brandon Clay, who focuses on a China ETF as his latest investment idea.

In his All Star Investor newsletter, he explains, "Beyond this, in 2010, we will see the World Expo in Shanghai and the Asian Games in Guangzhou." So is now a good time to invest in China? Here's the advisor's assessment and his top pick for exposure to the region.

"China has been gearing up for the Games for the past few years. Finally, with a dozen new sports stadiums and a cross-city underground railway to ferry visitors to different venues, China will be on display to the world.

"If you've been investing internationally, you're no stranger to China. Depending on when you bought, you may either love it or hate it. For instance, in 2007 Chinese stocks rocketed up the charts 97%.

"In 2006, the gains were even more impressive at 130%! But it hasn't been all fun and games in the past two years. China peaked at the same time U.S. stocks in October 2007.

Continue reading Olympic gains for China stocks? Look at FXI to play the games and beyond

Olympic gains for China stocks? Look at FXI to play the games and beyond originally appeared on BloggingStocks on Fri, 08 Aug 2008 10:30:00 EST. Please see our terms for use of feeds.

"We like to invest in the strongest sectors and we think Industrials are on their way to the top," note Ron Rowland and Brandon Clay in All Star Investor.

The advisors explain, "Surveying the horizon of industrial companies, the most promising is Bermuda-based, Ingersoll-Rand (NYSE: IR). This is a stock you want for the next 12 months."

"The stock market is a leading indicator; it starts to decline before the economy slows down, and it starts to advance well before the economy improves. These lags often results in a stock market that starts moving up just when the public becomes 'convinced' that the problems are serious.

"Economic reports are likely to get worse. Housing foreclosures are likely to increase. Many more employees are likely to be let go. These are the perceptions that currently haunt investors.

"However, these are often the very same perceptions that create bottoms in the stock market. It is hard to see how the economy will crawl out of this mess, but eventually it will. The groundwork is now being laid.

"It may seem counter-intuitive, but investors should start planning for the next expansionary cycle. Markets move well ahead of facts, and it's time to invest accordingly. And indeed, industrials have risen in our rankings in recent weeks.

"A global leader of broad-based equipment offerings, Ingersoll-Rand is positioned to capitalize on the next phase of development like no other company in its sector. Here's why.

Continue reading Ingersoll-Rand (IR): It's time for Industrials

Ingersoll-Rand (IR): It's time for Industrials originally appeared on BloggingStocks on Tue, 08 Apr 2008 13:14:00 EST. Please see our terms for use of feeds.